medigraphic.com
SPANISH

Salud Mental

ISSN 0185-3325 (Print)
Órgano Oficial del Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2008, Number 2

<< Back Next >>

Salud Mental 2008; 31 (2)

Deficiencias mnésicas, ejecutivas y atencionales como endofenotipos neurocognitivos en el trastorno bipolar: una revisión

Castañeda FM, Tirado DE
Full text How to cite this article

Language: Spanish
References: 52
Page: 145-150
PDF size: 116.47 Kb.


Key words:

Endophenotype, neurocognitive assessment, bipolar disorder, attention, memory, executive functions, neuropsychological assessment, neuroimaging.

ABSTRACT

Although many studies have demonstrated that bipolar disorder (BD) is heritable, the disorder´s genetic basis remains elusive despite the substantial evidence. Hence, indicators of processes mediating between genotype and phenotype, known as endophenotypes, may be necessary to provide more information about this issue.
Given that endophenotypes could provide information for elucidating the genetic underpinnings of BD, many studies have focused on one class of endophenotypic marker, the neuropsychological measures. In order for a cognitive measure to be considered an endophenotype, it has to 1. be highly heritable, 2. be associated with the illness, 3. be independent of the clinical state and, 4. the impairment must co-segregate with the illness within a family, with non-affected family members showing impairment relative to general population.
In this sense, failures in attention, executive functions and verbal memory are the most consistently reported deficits with the characteristics for endophenotypes. With these factors in mind, the primary interest of this paper was to review the existing literature on neurocognitive functioning in BD as possible endophenotypes. Studies were identified by searching the major databases (MEDLINE and PSYCINFO) from 1990 to 2007 with the following key words: endophenotype, neurocognitive assessment, bipolar disorder, attention, memory, executive functions, neuropsychological assessment and neuroimaging. The titles and abstracts of the articles identified were examined and those that appeared to fullfil our inclusion criteria were retrieved. Articles were included if they met the following criteria: 1. included adult patients (aged: 16-65), 2. included a psychiatric or normal comparison group, 3. used well-established diagnostic criteria to ascertain diagnosis (DSM, 3rd. and 4th. eds.), 4. provided information about the clinical status of the patients being assessmed and 5. cognitive assessment was based on standardized or well established cognitive tasks.
Declarative memory has been studied in BD patients through tests that imply learning of words and stories to evaluate immediate memory, delayed recall and recognition, also considering the kind of strategies that the patients use to evoke verbal material. It seems that BD patients in depressive phase present deficits in immediate memory and delayed recall, but recognition memory is preserved. This impairment is due to difficulties in the planning and evoking strategies used, associated to prefrontal dysfunction. In manic phase, the patients make a lot of irrelevant associations because the failure in the system to control impulses. In the absence of the depressive and maniac symptoms, patients continue with anomalies in memory. Euthymic patient can use a similar semantic clustering strategy so that they can recall and recognize fewer words than controls, suggesting impaired encoding of verbal information and there is lack of rapid forgetting, which suggests a relative absence of a storage deficit.
Results of studies in declarative memory impairment in BD suggests that the impairments are consistent with deficits in learning, but do not appear to be related to different organizational strategies during learning, and do not appear to be secondary to clinical state. Rather, they are associated with the underlying pathophysiology of the illness. Regarding executive functions, patients with BD have deficiencies related to planning, organizational strategies, lack of control in the action, conceptual formation and cognitive flexibility. In depressive phase, patients have problems with concept formation, meanwhile the deficit in verbal fluency is due because they use phonemic rather than semantic clues.
In maniac episodes, the executive functions are altered, and it is observed that concept formation and attentional shift are deficient and more evident in patients with a history of psychosis. These deficits explain why maniac persons engage in more risk behaviors, specifically in the inhibiting impulses system. Also in the absence of symptoms, euthymic bipolar disorder patients show no significant differences with respect to controls on attentional set-shifting, problem solving or planning. However, they show qualitative differences involving slower functioning on measures of speed and slower to initiate a response, and present more errors across measures of verbal fluency.
With respect to attentional deficits in BD, several studies have pointed to deficits in sustained attention, also known as concentration, related to the capability to sustain the focus during a considerable amount of time. This attentional domain is deficient in manic patients because the lack of behavioral inhibition which is prevalent in this phase, the increased false responding (commission errors), perseveration and vigilance deficits. In contrast, when patients are depressive, they make more mistakes by omission of relevant stimuli. Also in euthymic patients, a deficit in the inattentive component of sustained attention is reported because of decreased target sensitivity (omission errors) and response time inconsistency.
It is possible that the observed findings do not reflect dysfunction in one isolated brain area, rather a dysregulation of cortical modulation of subcortical networks is considered. In particular, a neuroanatomic model of mood regulation comprising the prefrontal cortex, amygdala-hippocampal complex, thalamus, basal ganglia, and their inter-connections has been proposed to be implicated in the pathophysiology of mood disorders.
Functional neuroimaging studies also support evidence of these neurocognitive anomalies through the application of neuropsychological paradigms, in which metabolic increments in ventral striate and diminished function in prefrontal cortex during executives assignments is common. During maniac or hypomaniac episodes, an increment of activity in the ventral prefrontal cortex of the right hemisphere was observed; meanwhile, in depressive phase the patients show an increase in the same sector but in the left hemisphere compared to euthymic patients. During the depressive episodes of the BD type II, it is observed a reduction of the dorsolateral and medial prefrontal cortex metabolism, and an increase in thalamus and amygdala while resolving cognitive activities. Finally, there is a reduction of metabolism in ventral caudal and prefrontal cortex and an increase in amygdala in patients without depressive or maniac symptoms. This finding supports the hypothesis of permanent prefrontal dysfunction although the absence of clinical symptoms.
Finally, as Glahn et al. (2004) have suggested, neurocognitive markers may indicate the presence of quantifiable deviation on a genetically influenced dimension that underlies BD. Such endophenotypes would not identify illness genes per se; rather they would indicate a realiably characterized heritable behavioral phenomenon. Nevertheless, at present it is not known which of the many candidate genes for BD may be associated with neurocognitive endophenotypes for the disorder. Some studies have reported promising preliminary findings indicating a relationship between executive performance and a brain-derived neurotrophic factor gene polymorphism. Given that this gene has been implicated in memory and learning as a function of its role in synaptic transmission, and other genetic association studies have linked this gene to risk for BD, allelic variation in this gene may be associated with cognitive dysfunction in BD.


REFERENCES

  1. Almazy L, Blangero J. Endophenotypes as quantitative risk factors for psychiatric disease: rationale and study design. Am J Med Genet 2001;105:42-44.

  2. Gottesman I, Gould T. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 2003;160:636-645.

  3. Glahn D, Bearden C, Niendam T et al. The feasibility of neuropsychological endophenotypes in the search for genes associated with bipolar affective disorder. Bipolar Disord 2004;6:171-182.

  4. Lezak M. Neuropsychological assessment. New York: Oxford University Press; 2004.

  5. Delis D, Kramer J, Kaplan E et al. The California Verbal Learning Test. New York: Psychological Corporation; 1987.

  6. Atre-Vaidya N, Taylor M, Seidenberg M et al. Cognitive deficits, psychopathology and psychosocial functioning in bipolar mood disorder. Neuropsychiatry, Neuropsychol Behav Neurol 1998;11:120-126.

  7. Van Gorp W, Altshuler L, Theberge D et al. Cognitive impairment in euthymic bipolar patients with and without prior alcohol dependence. Arch Gen Psychiatry 1998;55:41-46.

  8. Van Gorp W, Altshuler L, Theberge D. Declarative and procedural memory in bipolar disorder. Boil Psychiatry 1999;46:525-531.

  9. Cavanagh J, Van Bechk M, Muir W et al. Case-control study of neurocognitive function in euthymic patients with bipolar disorder: an association with mania. Br J Psychiatry 2002;180:320-326.

  10. Fleck D, Shear P, Zimmerman M. Verbal memory in mania: effects of clinical state and task requirements. Bipolar Dis 2003;5:375-380.

  11. Martinez-Aran A, Vieta E, Reinares M. Cognitive function across manic or hypomanic, depressed , and authymic states in bipolar disorder. Am J Psychiatry 2004;161:262-270.

  12. Clark L, Iversen S, Goodwin G. A neuropsychological investigation of prefrontal cortex involvement in acute mania. Am J Psychiatry 2001;158:1605-1611.

  13. Rey A. L´Examen Clinque en Psychologie. Paris: Press Universitaire de France; 1964.

  14. Ferrier I, Stanton B, Kelly T et al. Neuropsychological function in euthymic patients with bipolar disorder. Br J Psychiatry 1999;175:246-251.

  15. Krabbendam L, Honing A, Weisman J et al. Cognitive dysfunctions and white matter lesions in patients with bipolar disorder in remission. Acta Psychiatr Scand 2000;101:274-280.

  16. Zubieta J, Huguelet P, O´Neil R. Cognitive function in euthymic bipolar I disorder. Psychiatry Res 2001;102:9-20.

  17. Bearden C, Glahn D, Monkul S et al. Sources of declarative memory impairment in bipolar disorder: mnemonic processes and clinical features. J Psychiatric Res 2006;40:47-58.

  18. Brâebion G, Gorman J, Amador X et al. Source monitoring impairments in schizophrenia: characterization and associations with positive and negative symptomatology. Psychiatry Res 2002;112 (1):27-39.

  19. Schacter D, Norman K, Koutstaal W. The cognitive neuroscience of constructive memory. Ann Rev Psychology 1998;49.

  20. Rubinsztein J, Michael A, Paykel E et al. Cognitive impairment in remission in bipolar affective disorder. Psychol Med 2000;30:1025-1036.

  21. Fossati P, Deweer B, Raoux N et al. Les troubles de la récupération mnésique; un argument en faveur d´un dysfonctionnement des structures sous-cortico-frontales dans la depresión. Encépale 1995;21:295-305.

  22. Ilsley J, Mofoot A, O´Carroll R. An analysis of memory dysfunction in major depression. J Affect Disord 1995;35:1-9.

  23. Dhingra U, Rabins P. Mania in the elderly: a 5-7 year follow-up. J Am Geriatr Soc 1991;39:581-583.

  24. Sweeney J, Kmiec J, Kupfer D. Neuropsychologic impairments in bipolar and unipolar mood disorders on the CANTAB neurocognitive battery. Biol Psychiatry 2000;48:674-685.

  25. Martínez-Arán A: Deterioro cognitivo y trastorno bipolar. I Congreso virtual de Psiquiatría 1 de febrero - 15 de marzo 2000 (citado 11/02/06); conferencia 31-CI-A: (24 pantallas). http://www.psiquiatria.com/congreso/ mesas/mesa31/conferencias/31_ci_a.htm

  26. Iacono W. Identifying genetic risk for psychopathology. The science of clinical psychology: accomplishments and future directions: Washington: American Psychological Association; 1998.p.3-22.

  27. El-Badri S, Ashton C, Moore P. Electrophysiological and cognitive function in young euthymic patients with bipolar affective disorder. Bipolar Disord 2001;3:79-87.

  28. Zalla T, Joyce C, Szoke A. Executive dysfunctions as potential markers of familiar vulnerability to bipolar disorder and schizophrenia. Psychiatry Res 2004;121:207-217.

  29. Hawkins K, Hoffman R, Quinlan D et al. Cognition, negative symptoms, and diagnosis: a comparison of schizophrenic, bipolar, and control samples. J Neuropsych Clin Neurosci 1997;9:81-89.

  30. Gourovitch M, Torrey E, Gold J. Neuropsychological performance of monozygotic twins discordant for bipolar disorder. Biol Psychiatry 1999;45:639-646.

  31. McGrath J, Scheldt S, Welham J. Performance on pruebas sensitive to impaired executive ability in schizophrenia, mania and well controls: acute and subacute phases. Schizophr Res 1997;26:127-137.

  32. Murphy F, Sahakian J. Neuropsychology of bipolar disorder. Br J Psychiatry 2001; 178:s120-s127.

  33. Porter R, Gallagher P, Thompson J et al. Neurocognitive impairment in drug-free patients with major depressive disorder. Br J Psychiatry 2003;182:214-220.

  34. Albus M, Hubmann W, Wahlheim C et al. Contrasts in neuropsychological test profile between patients with first-episode schizophrenia and first-episode affective disorders. Acta Psychiatr Scand 1996;94:87-93.

  35. Goodwin F, Jamison K. Manic-depressive Illness. New York: Oxford University Press; 1990.

  36. Olley A, Malhi G, Bachelor J et al. Executive functioning and theory of mind in euthymic bipolar disorder. Bipolar Dis 2005;7:43-52.

  37. Rossi A, Arduini L, Daneluzzo E et al. Cognitive function in euthymic bipolar patients, stabilized schizophrenic patients, and healthy controls. J Psychiatr Res 2000;34:333-339.

  38. Rosvold H, Mirsky A, Sarason I et al. A continuous performance test of brain damage. J Consult Psychol 1956;20:343-350.

  39. Clark L, Iversen S, Goodwin G. Sustained attention deficit in bipolar disorder. Br J Psychiatry 2002;180:313-9.

  40. Wilder-Willis K, Sax K, Rosenberg H. Persistent attentional dysfunction in remitted bipolar disorder. Bipolar Disord 2001;3:58-62.

  41. Harmer C, Clark L, Grayson L. Sustained attention déficit in bipolar disorder is not a working memory impairment in disguise. Neuropsychologia 2002;40:1586-1590.

  42. Bora E, Vahips, Gonula et al. Evidence for theory of mind deficits in euthymic patients with bipolar disorder. Acta Psychiatr Scand 2005;112:110-116.

  43. Clark L, Goodwin G. State and trait related deficits in sustained attention in bipolar disorder. Eur Arch Psychiatry Clin Neurosci 2004;254:61-68.

  44. Liu S, Chiu Ch, Chang C et al. Deficits in sustained attention in schizophrenia and affective disorders: stable versus state dependent markers. Am J Psychiatry 2002;159:975-982.

  45. Swann A, Pazzaglia P, Nicholls A et al. Impulsivity and phase of illness in bipolar disorder. J Affect Disord 2003;73:105-111.

  46. Bora E, Vahip S, Akdeniz F: Sustained attention deficits in manic and euthymic patients with bipolar disorder. Prog Neuro-psychopharmacol Biol Psychiatry 2006;30:1097-1102.

  47. Soares J, Mann J. The anatomy of mood disorders- review of structural neuroimaging studies. Biol Psychiatry 1997;41:86-106.

  48. Goodwin G, Cavanagh J, Glabus M et al. Uptake of 99 mTc-exametazime shown by single photon emission computed tomography before and after lithium withdrawal in bipolar patients: associations with mania. Br J Psychiatry 1997;170:426-430.

  49. Ketter T, Kimbrell T, George M et al. Effects of mood and subtype on cerebral glucose metabolism in treatment-resistant bipolar disorder. Biol Psychiatry 2001;49:97-109.

  50. Blumberg H, Leung H, Skudlarski P et al. A functional magnetic resonance imaging study of bipolar disorder: state – and trait-related dysfunction in ventral prefrontal cortices. Arch Gen Psychiatry 2003;60: 601-609.

  51. Rybakowskia J, Borkowskab A, Czerkic P. Polymorphism of the brainderive neurotrophic factor gene and performance on a cognitive prefrontal test in bipolar patients. Bipolar Disord 2003;5:468-472

  52. Egan M, Kojima M, Callicott J. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003;112:257-269.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Salud Mental. 2008;31